Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00884_DB01164_nanopub.RAzcHN_og2Yk9x5ON_TcW6ZfdJP35bFNy_Fp4KMi-XQvY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00884_DB01164 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00884_DB01164 label "DDI between Risedronate and Calcium Chloride - Calcium salts may decrease the serum concentration of bisphosphonate derivatives. Avoid administration of oral calcium supplements within 30 minutes after alendronate/risedronate. [drugbank_resource:DB00884_DB01164]" assertion.
- drugbank_resource:DB00884_DB01164 identifier "drugbank_resource:DB00884_DB01164" assertion.
- drugbank_resource:DB00884_DB01164 title "DDI between Risedronate and Calcium Chloride - Calcium salts may decrease the serum concentration of bisphosphonate derivatives. Avoid administration of oral calcium supplements within 30 minutes after alendronate/risedronate." assertion.
- drugbank:DB01164 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00884_DB01164 assertion.
- drugbank:DB00884 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00884_DB01164 assertion.